A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Prostate CancerHead & Neck CancerEsophageal Cancer
Interventions
DRUG

panobinostat

Trial Locations (1)

Unknown

Novartis Investigative Site, Liège

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY